Contribution of gluconeogenesis and glycogenolysis to hepatic glucose production in acromegaly before and after pituitary microsurgery

被引:18
作者
Hoybye, C. [1 ]
Chandramouli, V. [2 ]
Efendic, S. [1 ]
Hulting, A. -L. [1 ]
Landau, B. R. [2 ]
Schumann, W. C. [2 ]
Wajngot, A. [3 ]
机构
[1] Karolinska Univ Hosp, Dept Endocrinol Metab & Diabetol, S-17176 Stockholm, Sweden
[2] Case Western Reserve Univ, Dept Med, Cleveland, OH 44106 USA
[3] Karolinska Univ Hosp, LUCD, S-17176 Stockholm, Sweden
关键词
growth hormone excess; regulation of glucose metabolism; hepatic glucose production; gluconeogenesis; glycogenolysis; insulin resistance;
D O I
10.1055/s-2008-1065322
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The diabetogenic effect of excess growth hormone (GH) such as that in acromegaly is well known. However, the contribution of the various components to hepatic glucose production (HGP) is not completely understood. in this study we evaluated insulin resistance, HGP, gluconeogenesis (GNG), and glycogenolysis (GLY) in five patients with acromegaly before and after pituitary microsurgery. Insulin resistance was estimated by the HOMA index. HGP was measured using a primed continuous (6,62-(2)H(2)) glucose infusion, and GNG was measured from 2 H enrichment at carbons 2 and 5 of blood glucose on ingestion of (2)H(2)O. The ratio of these enrichments equals the fractional contribution of GNG to HGP, and GLY was calculated as the difference between HGP and GNG. All measurements were performed after 12 hours of fasting. Levels of GH and IGF-I decreased, as did the HOMA index (p<0.05). HGP was reduced from 11.4 mu mol/kg/ min to 9.7 mu mol/kg/min (p = 0.032). GNG contributed most to HGP. GNG was unchanged, whereas GLY's fraction decreased 29% (p=0.056) post-operatively. This pilot study indicates that GNG is the main contributor to HGP and that GLY is more sensitive than is GNG to the insulin resistance existing in acromegaly.
引用
收藏
页码:498 / 501
页数:4
相关论文
共 22 条
  • [1] Higher insulin concentrations are required to suppress gluconeogenesis than glycogenolysis in nondiabetic humans
    Adkins, A
    Basu, R
    Persson, M
    Dicke, B
    Shah, P
    Vella, A
    Schwenk, WF
    Rizza, R
    [J]. DIABETES, 2003, 52 (09) : 2213 - 2220
  • [2] Assessment of insulin sensitivity and beta-cell function from measurements in the fasting state and during an oral glucose tolerance test
    Albareda, M
    Rodríguez-Espinosa, J
    Murugo, M
    de Leiva, A
    Corcoy, R
    [J]. DIABETOLOGIA, 2000, 43 (12) : 1507 - 1511
  • [3] Prevalence of insulin resistance in metabolic disorders - The Bruneck Study
    Bonora, E
    Kiechl, S
    Willeit, J
    Oberhollenzer, F
    Egger, G
    Targher, G
    Alberiche, M
    Bonadonna, RC
    Muggeo, M
    [J]. DIABETES, 1998, 47 (10) : 1643 - 1649
  • [4] EFFECTS OF HYPOPITUITARISM AND GROWTH-HORMONE REPLACEMENT THERAPY ON THE PRODUCTION AND UTILIZATION OF GLUCOSE IN CHILDHOOD
    BOUGNERES, PF
    ARTAVIALORIA, E
    FERRE, P
    CHAUSSAIN, JL
    JOB, JC
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1985, 61 (06) : 1152 - 1157
  • [5] LONG-TERM EFFECT OF OCTREOTIDE IN ACROMEGALY ON INSULIN-RESISTANCE
    BREIDERT, M
    PINZER, T
    WILDBRETT, J
    BORNSTEIN, SR
    HANEFELD, M
    [J]. HORMONE AND METABOLIC RESEARCH, 1995, 27 (05) : 226 - 230
  • [6] Quantifying gluconeogenesis during fasting
    Chandramouli, V
    Ekberg, K
    Schumann, WC
    Kalhan, SC
    Wahren, J
    Landau, BR
    [J]. AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM, 1997, 273 (06): : E1209 - E1215
  • [8] Small increases in insulin inhibit hepatic glucose production solely caused by an effect on glycogen metabolism
    Edgerton, DS
    Cardin, S
    Emshwiller, M
    Neal, D
    Chandramouli, V
    Schumann, WC
    Landau, BR
    Rossetti, L
    Cherrington, AD
    [J]. DIABETES, 2001, 50 (08) : 1872 - 1882
  • [9] Influence of obesity and type 2 diabetes on gluconeogenesis and glucose output in humans - A quantitative study
    Gastaldelli, A
    Baldi, S
    Pettiti, M
    Toschi, E
    Camastra, S
    Natali, A
    Landau, BR
    Ferrannini, E
    [J]. DIABETES, 2000, 49 (08) : 1367 - 1373
  • [10] Growth hormone administration increases glucose production by preventing the expected decrease in glycogenolysis seen with fasting in healthy volunteers
    Ghanaat, F
    Tayek, JA
    [J]. METABOLISM-CLINICAL AND EXPERIMENTAL, 2005, 54 (05): : 604 - 609